Therefore, together with phospho-p70S6K, phospho-S6 and phospho-4E-BP1, ACSL4 appears to be a useful predictor of mTOR activity and whether breast tumors will respond to the inhibition of mTOR. This evidence concerns the gene RPS6 and breast neoplasm.